| MR编号 | IE/H/1240/001 |
|---|
| 药品名称 | Perindopril arginin/Amlodipine besilate/Indapamide 5mg/5mg/1.25mg |
|---|
| 活性成分 | - AMLODIPINE BESILATE 5.0 mg
- indapamide 1.25 mg
- PERINDOPRIL ARGININE 5.0 mg
|
|---|
| 剂型 | Tablet |
|---|
| 上市许可持有人 | KRKA, d.d., Novo mesto,
Šmarješka cesta 6, 8501 Novo mesto
Slovenia |
|---|
| 参考成员国 - 产品名称 | Ireland (IE) |
|---|
| 互认成员国 - 产品名称 | - Hungary (HU)
CO-DALNESSA-AS 5 mg/1,25 mg/5 mg, 10/2,5/5 mg, 10/2,5/10 mg tabletta - Bulgaria (BG)
Co-Amlessa Neo - Cyprus (CY)
CO-APERNEVA 5 mg/1,25 mg/5 mg δισκία - Czechia (CZ)
Tonanda Neo - Germany (DE)
Co-Amlessa 5 mg/1,25 mg/5 mg Tabletten - Romania (RO)
Co-Amlessaneo 5 mg/1,25 mg/5 mg comprimate - Belgium (BE)
- Slovakia (SK)
- Portugal (PT)
- Slovenia (SI)
- Greece (GR)
- Croatia (HR)
- Poland (PL)
- Latvia (LV)
- Lithuania (LT)
Perindopril arginine/indapamide/amlodipine Krka 5 mg/1,25 mg/5 mg tabletės - Estonia (EE)
|
|---|
| 许可日期 | 2024/03/14 |
|---|
| 最近更新日期 | 2024/03/14 |
|---|
| 药物ATC编码 | - C09BX01 perindopril, amlodipine and indapamide
| 申请类型 | - TypeLevel1：Known Active Substance
- TypeLevel2：Initial Application
- TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|